Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.18 - $0.86 $5,685 - $27,163
-31,585 Closed
0 $0
Q1 2022

Apr 26, 2022

BUY
$0.6 - $1.06 $300 - $530
500 Added 1.61%
31,585 $19,000
Q4 2021

Jan 20, 2022

BUY
$0.85 - $1.4 $425 - $700
500 Added 1.63%
31,085 $27,000
Q2 2021

Jul 28, 2021

BUY
$1.41 - $1.94 $43,124 - $59,334
30,585 New
30,585 $44,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.